Mark Leschly, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 13,067 shares at $22.50 ($294K) on 2014-08-27, disclosed to the SEC on 2014-08-29.
Open-market sale of $294k ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BFLY | BUY | 2012-11-15 | $299K | — | Filing → |
| ANAC | BUY | 2010-12-01 | $12.0M | — | Filing → |
| AVNC | BUY | 2007-04-16 | $2.8M | — | Filing → |